Costs of $259,324 incurred by adolescent, young adult cancer survivors

by Elana GotkineAdolescent and young adult (AYA) cancer survivors incur costs of $259,324 over their lifetime, according to a study published online Feb. 24 in theJournal of Clinical Oncology.Su

Updated on: January 02,2024 9

Costs of $259,324 incurred by adolescent, young adult cancer survivors

by Elana GotkineAdolescent and young adult (AYA) cancer survivors incur costs of $259,324 over their lifetime, according to a study published online Feb. 24 in theJournal of Clinical Oncology.Su

Updated on:January 02,2024 9

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on: January 23,2024 15

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on:January 23,2024 15

Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on: June 19,2024 8

Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on:June 19,2024 8

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d

Updated on: February 18,2024 13

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d

Updated on:February 18,2024 13

New study finds disparities caused by algorithm in health care systems

by Drew Wiseman, Huntsman Cancer InstituteCredit: CC0 Public DomainPatients from historically medically underserved groups, including patients of color and those who are Spanish-speaking, have less ca

Updated on: February 01,2024 20

New study finds disparities caused by algorithm in health care systems

by Drew Wiseman, Huntsman Cancer InstituteCredit: CC0 Public DomainPatients from historically medically underserved groups, including patients of color and those who are Spanish-speaking, have less ca

Updated on:February 01,2024 20

Researchers use a new approach to hit an 'undruggable' target

by University of MichiganGraphical abstract. Credit:Nature Chemical Biology(2023). DOI: 10.1038/s41589-022-01248-4The protein STAT5 has long been an appealing target against cancer, b

Updated on: February 18,2024 20

Researchers use a new approach to hit an 'undruggable' target

by University of MichiganGraphical abstract. Credit:Nature Chemical Biology(2023). DOI: 10.1038/s41589-022-01248-4The protein STAT5 has long been an appealing target against cancer, b

Updated on:February 18,2024 20

Cell fate choice during adult regeneration is highly disorganized, study finds

by Nicole Davis,Whitehead Institute for Biomedical ResearchMERFISH labeling of major tissue classes in a thin sagittal section. Cartoon represents spatial location of depicted region. Scale bar,

Updated on: January 23,2024 16

Cell fate choice during adult regeneration is highly disorganized, study finds

by Nicole Davis,Whitehead Institute for Biomedical ResearchMERFISH labeling of major tissue classes in a thin sagittal section. Cartoon represents spatial location of depicted region. Scale bar,

Updated on:January 23,2024 16

Staying safe in the sun — a dermatologist helps separate facts from hype

by University of California, San FranciscoCredit: Elena ZhukovaSkin cancer is the number-one cancer diagnosis in the United States – it's more common than breast, prostate, and lung cancers c

Updated on: April 20,2024 17

Staying safe in the sun — a dermatologist helps separate facts from hype

by University of California, San FranciscoCredit: Elena ZhukovaSkin cancer is the number-one cancer diagnosis in the United States – it's more common than breast, prostate, and lung cancers c

Updated on:April 20,2024 17

Diabetes drug reduces drug resistance in lung cancer, improving chemotherapy effectiveness

byUniversity of MissouriCredit: Pixabay/CC0 Public DomainA medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according t

Updated on: August 01,2024 0

Diabetes drug reduces drug resistance in lung cancer, improving chemotherapy effectiveness

byUniversity of MissouriCredit: Pixabay/CC0 Public DomainA medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according t

Updated on:August 01,2024 0

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and

Updated on: July 17,2024 0

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and

Updated on:July 17,2024 0

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on: April 10,2024 12

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on:April 10,2024 12

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient

Updated on: April 14,2024 18

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient

Updated on:April 14,2024 18